2026 | 2025 | |||
Note | £m | £m | ||
Revenue | 2 | |||
Cost of sales | ( | ( | ||
Gross profit | ||||
Selling and distribution expense | ( | ( | ||
Administrative expense | ( | ( | ||
Other operating income | 3 | |||
Gain on disposal of joint venture undertakings | 29 | |||
Share of results of joint venture | 14 | |||
Operating profit | 2 | |||
Finance income | ||||
Finance expense | ( | ( | ||
Net finance expense | 6 | ( | ( | |
Profit before taxation | ||||
Taxation | 7 | ( | ( | |
Profit/(loss) for Attributable to: | the year 1 | 4 | ( | |
Owners of the Parent | ( | |||
Non-controlling interests | ||||
( | ||||
pence | pence | |||
Profit/(loss) per share 1 | ||||
Basic (p) | 9 | ( | ||
Diluted (p) 2 | 9 | ( |
2026 | 2025 | ||
Note | £m | £m | |
Profit/(loss) for the year | ( | ||
| Other comprehensive (expense)/income | |||
| Items that will not be reclassified subsequently to income statement | |||
Re-measurement loss on net retirement benefit surplus | 23 | ( | ( |
Taxation on items that will not be reclassified to income statement | 21 | ||
Total items that will not be reclassified to income statement | ( | ( | |
| Items that may be reclassified subsequently to income statement | |||
Exchange differences on translation of foreign operations 1 | |||
Reclassification of currency translation reserve on the disposal of joint venture undertaking | 29 | ||
Share of other comprehensive expense of joint venture accounted for using the equity method | ( | ||
Cash flow hedges – fair value movements | ( | ||
Taxation on items that may be subsequently reclassified to income statement | 21 | ||
Total items that may be subsequently reclassified to income statement | ( | ||
Other comprehensive income/(expense) for the year | ( | ||
Total comprehensive income/(expense) for the year | ( | ||
| Attributable to: | |||
Owners of the Parent | ( | ||
Non-controlling interests | |||
( |
2026 | 2025 | ||
Note | £m | £m | |
| Assets | |||
| Non-current assets | |||
Goodwill and other intangible assets | 10 | ||
Property, plant and equipment | 11 | ||
Investment properties | 12 | ||
Right-of-use assets | 13 | ||
Net investment in joint venture | 14 | ||
Trade and other receivables | 17 | ||
Deferred tax assets | 21 | ||
Tax receivable | |||
Retirement benefit surplus | 23 | ||
| Current assets | |||
Inventories | 16 | ||
Trade and other receivables | 17 | ||
Derivative financial assets | 19 | ||
Current taxation receivable | |||
Cash and cash equivalents | 18 | ||
Assets held for sale | 15 | ||
Total assets | |||
| Equity | |||
Share capital | 24 | ||
Treasury shares | 24 | ( | ( |
Capital redemption reserve | |||
Hedging reserve | 19 | ( | ( |
Currency translation reserve | ( | ( | |
Retained earnings | |||
Other reserves | |||
Attributable to owners of the Parent | |||
Non-controlling interests | ( | ||
Total equity |
2026 | 2025 | ||
Note | £m | £m | |
| Liabilities | |||
| Non-current liabilities | |||
Borrowings | 18, 19 | ||
Trade and other payables | 20 | ||
Lease liabilities | 18, 19 | ||
Deferred taxation liabilities | 21 | ||
Retirement and other long-term employee benefit obligations | 23 | ||
| Current liabilities | |||
Borrowings | 18, 19 | ||
Trade and other payables | 20 | ||
Lease liabilities | 18, 19 | ||
Derivative financial liabilities | 19 | ||
Current taxation payable | |||
Provisions | 22 | ||
Total liabilities | |||
Total equity and liabilities |
| Attributable to owners of the Parent | ||||||||||
| Capital | Currency | Non- | ||||||||
| Share | Treasury | redemption | Hedging | translation | Retained | Other | controlling | |||
| capital | shares | reserve | reserve 1 | reserve 2 | earnings | reserves 3 | interests 4 | Total | ||
Note | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 June 2024 | ( | ( | ( | ( | ||||||
(Loss)/profit for the year | ( | ( | ||||||||
| Other comprehensive income/ | ( | ( | ||||||||
| (expense) | ||||||||||
| Total comprehensive income/ | ( | ( | ||||||||
| (expense) for the year | ||||||||||
| Transactions with owners: | ||||||||||
Ordinary dividends | 8 | ( | ( | |||||||
Share-based payments | 25 | ( | ||||||||
Shares issued from ESOT | ( | |||||||||
| Total transactions with owners | ( | ( | ( | |||||||
| recognised directly in equity | ||||||||||
At 31 May 2025 | ( | ( | ( | ( | ||||||
At 1 June 2025 | ( | ( | ( | ( | ||||||
Profit for the year | ||||||||||
| Reclassification of currency | ||||||||||
| translation reserve on the disposal | 29 | |||||||||
| of joint venture undertaking | ||||||||||
| Other comprehensive (expense)/ | ( | ( | ( | ( | ||||||
| income | ||||||||||
| Total comprehensive (expense)/ | ( | |||||||||
| income for the year | ||||||||||
| Transactions with owners: | ||||||||||
Ordinary dividends | 8 | ( | ( | |||||||
Share-based payments | 25 | |||||||||
Shares issued from ESOT | ( | |||||||||
| Total transactions with owners | ( | ( | ||||||||
| recognised directly in equity | ||||||||||
At 31 May 2026 | ( | ( | ( |
2026 | 2025 | ||
Note | £m | £m | |
| Cash flows from operating activities | |||
Cash generated from operations | 26 | ||
Interest paid | ( | ( | |
Taxation paid | ( | ( | |
Net cash generated from operating activities | |||
| Cash flows from investing activities | |||
Interest received | |||
Purchase of fixed assets | 10,11,12 | ( | ( |
Proceeds from disposal of fixed assets | 11,12 | ||
Proceeds from disposal of joint venture | 29 | ||
Proceeds from disposal of current asset investment | |||
Rental income | 12 | ||
Loan repayments from joint venture | 29 | ||
Net cash generated from investing activities | |||
| Cash flows from financing activities | |||
Dividends paid to Company shareholders | 8 | ( | ( |
Acquisition of non-controlling interests | ( | ||
Repayment of lease liabilities (principal) | ( | ( | |
Repayment of borrowings | ( | ( | |
Proceeds from borrowings | |||
Financing fees paid on committed credit facility | ( | ||
Net cash used in financing activities | ( | ( | |
Net increase/(decrease) in cash and cash equivalents | ( | ||
Effect of foreign exchange rates | ( | ||
Cash and cash equivalents at the beginning of the year | |||
Cash and cash equivalents at the end of the year | 18 |
| Europe & the | ||||||
Americas | Asia Pacific | Africa | Central | Eliminations | Total | |
2026 | £m | £m | £m | £m | £m | £m |
Gross segment revenue | 202.2 | 176.4 | 168.0 | 46.4 | (51.6) | 541.4 |
Inter-segment revenue | (1.9) | (3.3) | — | (46.4) | 51.6 | — |
Revenue | 200.3 | 173.1 | 168.0 | — | — | 541.4 |
Segmental operating profit/(loss) before adjusting items | 36.6 | 23.9 | 21.9 | (22.9) | — | 59.5 |
Adjusting items | 10.6 | 3.2 | 12.3 | 1.2 | — | 27.3 |
Segmental operating profit/(loss) | 47.2 | 27.1 | 34.2 | (21.7) | — | 86.8 |
Finance income | 3.4 | |||||
Finance expense | (12.8) | |||||
Profit before taxation | 77.4 |
| Europe & the | ||||||
Americas | Asia Pacific | Africa | Central | Eliminations | Total | |
2025 | £m | £m | £m | £m | £m | £m |
Gross segment revenue | 202.5 | 175.3 | 140.9 | 40.2 | (45.1) | 513.8 |
Inter-segment revenue | (3.1) | (1.8) | — | (40.2) | 45.1 | — |
Revenue | 199.4 | 173.5 | 140.9 | — | — | 513.8 |
Segmental operating profit/(loss) before adjusting items and share of results of joint venture | 36.8 | 25.2 | 16.3 | (30.5) | — | 47.8 |
Share of results of joint venture | — | — | 7.1 | — | — | 7.1 |
Segmental operating profit/(loss) before adjusting items | 36.8 | 25.2 | 23.4 | (30.5) | — | 54.9 |
Adjusting items | 14.1 | (0.1) | (4.5) | (43.8) | — | (34.3) |
Segmental operating profit/(loss) | 50.9 | 25.1 | 18.9 | (74.3) | — | 20.6 |
Finance income | 3.9 | |||||
Finance expense | (18.0) | |||||
Profit before taxation | 6.5 |
| : £174.6 million), £133.0 million in Nigeria (2025: £105.5million), | |
| £91.3 million in Australia and New Zealand (2025: £88.5 million), and £68.8 million in Indonesia (2025: £68.5 million), representing the Group’s four |
| Re-stated | ||
| 2026 | 2025 | |
£m | £m | |
Personal Care | 271.3 | 269.2 |
Baby Care | 115.6 | 106.6 |
Home Care | 86.3 | 81.7 |
Electricals | 59.9 | 47.0 |
Other | 8.3 | 9.3 |
541.4 | 513.8 |
2026 | 2025 | |
£m | £m | |
Simplification and transformation 1 | (9.3) | 8.7 |
Acquisition and disposal-related items 2 | (3.2) | 1.7 |
Net impairment (reversal)/charge 4 | (11.4) | 18.8 |
Foreign exchange (gains)/losses arising on loans previously classified as permanent as equity 4 | (3.4) | 3.9 |
Foreign exchange losses arising on loans previously classified as permanent as equity to joint venture undertaking 3 | — | 1.5 |
Adjusting items before taxation | (27.3) | 34.6 |
Taxation | 34.1 | 2.7 |
Adjusting items after taxation | 6.8 | 37.3 |
| £m | |
Total proceeds (cash) | 27.5 |
| Net assets disposed: | |
– investment properties | (12.7) |
Transaction costs | (2.2) |
Gain on disposal | 12.6 |
2026 | 2025 | ||
Note | £m | £m | |
Net foreign exchange (gains)/losses | (3.5) | 7.8 | |
Research and development costs | 1.1 | 1.1 | |
Depreciation of property, plant and equipment | 11 | 5.6 | 5.1 |
Depreciation of investment properties | 12 | — | 0.1 |
Depreciation of right-of-use assets | 13 | 2.8 | 2.8 |
Profit on disposal of investment properties | 3 | (12.6) | (0.8) |
Profit on disposal of other assets | — | (0.3) | |
Profit on disposal of joint venture | 29 | (4.5) | — |
Amortisation of intangible assets | 10 | 4.1 | 4.1 |
Impairment of intangible assets, net of impairment reversal | 3, 10 | (11.4) | 18.8 |
2026 | 2025 | |
£m | £m | |
Fees payable to the Company’s Auditor for the audit of the Company’s annual financial statements and consolidation | 2.2 | 2.0 |
| Fees payable to the Company’s Auditor and their associates for other services to the Group: | ||
– audit of the Company’s subsidiaries | 0.7 | 2.0 |
Total audit fees | 2.9 | 4.0 |
| Fees payable to the Company’s Auditor and its associates for other services: | ||
– other assurance services 1 | 0.2 | 0.2 |
Total fees for non-audit services | 0.2 | 0.2 |
Total Auditor’s remuneration | 3.1 | 4.2 |
2026 | 2025 | |
number | number | |
Production | 1,163 | 1,379 |
Selling and distribution | 520 | 647 |
Administration | 358 | 385 |
2,041 | 2,411 |
2026 | 2025 | |
£m | £m | |
Wages and salaries | 65.4 | 64.6 |
Social security costs | 5.7 | 5.7 |
Other pension costs | 3.9 | 3.3 |
Share-based payments | 3.3 | 2.6 |
78.3 | 76.2 |
2026 | 2025 | |
£m | £m | |
Defined benefit schemes | 1.7 | 1.3 |
Defined contribution schemes | 1.9 | 1.8 |
Nigerian gratuity scheme | 0.3 | 0.2 |
3.9 | 3.3 |
2026 | 2025 | |
£m | £m | |
Finance income on cash and cash equivalents held | (1.8) | (2.4) |
Finance income on defined benefit pension schemes | (1.4) | (1.5) |
Finance income on lease receivable | (0.2) | — |
Finance income | (3.4) | (3.9) |
Finance expense on borrowings | 10.8 | 15.5 |
Finance expense on defined benefit pension schemes | 0.6 | 0.6 |
Finance expense on lease liabilities | 0.6 | 0.6 |
Change in fair value of deferred consideration | — | 0.3 |
Amortisation of financing fees | 0.8 | 1.0 |
Finance expense | 12.8 | 18.0 |
Net finance expense | 9.4 | 14.1 |
2026 | 2025 | |
£m | £m | |
| Current taxation | ||
| UK corporation tax | ||
– current year | 4.7 | 2.7 |
– adjustments in respect of prior years | (0.8) | (1.6) |
3.9 | 1.1 | |
| Overseas corporation tax | ||
– current year | 24.5 | 11.9 |
– adjustments in respect of prior years | 3.4 | (0.2) |
27.9 | 11.7 | |
Total current taxation charge | 31.8 | 12.8 |
| Deferred taxation | ||
Origination and reversal of temporary timing differences | 13.1 | 1.5 |
Adjustments in respect of prior years | 4.5 | (2.6) |
Effect of rate change adjustments | (0.4) | — |
Total deferred taxation charge/(credit) | 17.2 | (1.1) |
Total taxation charge | 49.0 | 11.7 |
| Analysed as: | ||
Taxation on profit before adjusting items | 14.9 | 9.0 |
Taxation on adjusting items | 34.1 | 2.7 |
49.0 | 11.7 |
2026 | 2025 | |
£m | £m | |
Profit before taxation | 77.4 | 6.5 |
Taxation at the UK corporation tax rate of 25% (2025: 25%) | 19.4 | 1.6 |
| Adjusted for: | ||
Effect of non-deductible expenses | 10.5 | 13.6 |
Effect of non-taxable income | (12.9) | (2.9) |
Effect of rate changes on deferred taxation (all territories) | (0.4) | — |
Taxation effect of share of results of joint venture | — | (1.8) |
Other taxes suffered outside of the UK | 11.8 | 3.0 |
Net adjustment to amount carried in respect of uncertain tax positions | 9.4 | 1.0 |
Movements in deferred taxation assets not recognised | 0.3 | 0.1 |
Adjustments in respect of prior years | 7.1 | (4.4) |
Differences in overseas rates | 3.8 | 1.5 |
Taxation charge for the year | 49.0 | 11.7 |
2026 | 2025 | |
£m | £m | |
| Amounts recognised as distributions to ordinary shareholders in the year comprise: | ||
Final dividend for the year ended 31 May 2025 of 2.10p (2024: 2.10p) per ordinary share | 8.8 | 8.8 |
Interim dividend for the year ended 31 May 2026 of 1.50p (2025: 1.50p) per ordinary share | 6.3 | 6.3 |
15.1 | 15.1 |
2026 | 2025 | |
number | number | |
000 | 000 | |
Average number of ordinary shares in issue during the year | 428,725 | 428,725 |
Less: weighted average number of treasury shares | (7,412) | (9,268) |
Basic weighted average shares in issue during the year | 421,313 | 419,457 |
Dilutive effect of share incentive schemes | 2,543 | 1,294 |
Diluted weighted average shares in issue during the year | 423,856 | 420,751 |
Goodwill | Software | Brands | Total | |
£m | £m | £m | £m | |
| Cost | ||||
At 1 June 2024 | 66.6 | 65.5 | 267.2 | 399.3 |
Additions | — | 0.4 | — | 0.4 |
Exchange differences | — | (0.1) | (2.8) | (2.9) |
At 31 May 2025 | 66.6 | 65.8 | 264.4 | 396.8 |
Additions | — | 0.5 | — | 0.5 |
Exchange differences | — | — | 3.6 | 3.6 |
At 31 May 2026 | 66.6 | 66.3 | 268.0 | 400.9 |
| Accumulated amortisation and impairment | ||||
At 1 June 2024 | 11.9 | 47.2 | 60.9 | 120.0 |
Amortisation charge | — | 4.1 | — | 4.1 |
Impairment charge | 35.3 | — | — | 35.3 |
Impairment reversal | — | — | (16.5) | (16.5) |
At 31 May 2025 | 47.2 | 51.3 | 44.4 | 142.9 |
Amortisation charge | — | 4.1 | — | 4.1 |
Impairment charge | — | — | 13.0 | 13.0 |
Impairment reversal | — | — | (24.4) | (24.4) |
At 31 May 2026 | 47.2 | 55.4 | 33.0 | 135.6 |
| Net book value | ||||
At 31 May 2026 | 19.4 | 10.9 | 235.0 | 265.3 |
At 31 May 2025 | 19.4 | 14.5 | 220.0 | 253.9 |
Goodwill | Brands | Goodwill | Brands | |
2026 | 2026 | 2025 | 2025 | |
£m | £m | £m | £m | |
Charles Worthington | 4.5 | 9.6 | ||
Fudge | 16.7 | 24.6 | ||
Sanctuary Spa | 75.4 | 51.0 | ||
St.Tropez | 58.4 | 58.4 | ||
Charles Worthington, Fudge, Sanctuary Spa and St.Tropez group of CGUs | 5.1 | 155.0 | 5.1 | 143.6 |
Original Source | — | 9.8 | — | 9.8 |
Rafferty's Garden | — | 34.7 | — | 31.1 |
Childs Farm | 13.5 | 35.5 | 13.5 | 35.5 |
Other | 0.8 | — | 0.8 | — |
19.4 | 235.0 | 19.4 | 220.0 |
| Long-term | Long-term | Pre-tax | Pre-tax | |||
CAGR 1 | CAGR 1 | growth rate 2 | growth rate | discount rate | discount rate | |
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
Charles Worthington | — | 2.5% | — | 2.0% | 12.8% | 13.0% |
Fudge | (1.3)% | 0.7% | — | 2.0% | 13.0% | 13.5% |
Sanctuary Spa | 5.9% | 3.1% | 2.0% | 2.0% | 12.8% | 13.0% |
St.Tropez | 5.4% | 1.3% | 2.0% | 2.0% | 13.3% | 13.5% |
| Charles Worthington, Fudge, Sanctuary Spa and St.Tropez | 4.6% | 2.0% | 1.7% | 2.0% | 13.1% | 13.3% |
| group of CGUs (goodwill assessment) | ||||||
Original Source | 9.2% | 10.2% | 2.0% | 2.0% | 12.9% | 13.1% |
Rafferty's Garden | 3.9% | 2.5% | 2.0% | 2.0% | 13.0% | 13.1% |
Childs Farm (brand and goodwill assessment) | 14.8% | 11.2% | 2.0% | 2.0% | 12.9% | 13.0% |
| Fixtures, | Assets in the | ||||
| Land and | Plant and | fittings and | course of | ||
| buildings | machinery | vehicles | construction | Total | |
£m | £m | £m | £m | £m | |
| Cost | |||||
At 1 June 2024 | 49.7 | 80.2 | 46.9 | 2.7 | 179.5 |
Additions | — | 0.1 | 0.2 | 6.0 | 6.3 |
Disposals | — | (1.6) | (7.8) | — | (9.4) |
Transfers | 0.3 | 2.7 | 0.8 | (3.8) | — |
Hyperinflationary adjustment 1 | 0.7 | — | — | — | 0.7 |
Exchange differences | (0.8) | (2.9) | (0.5) | (0.1) | (4.3) |
At 31 May 2025 | 49.9 | 78.5 | 39.6 | 4.8 | 172.8 |
Additions | — | 0.1 | 0.2 | 5.3 | 5.6 |
Disposals | (4.0) | (1.5) | (0.8) | — | (6.3) |
Transfers | 0.5 | 3.3 | 1.0 | (4.8) | — |
Exchange differences | 0.4 | (0.3) | 0.4 | — | 0.5 |
At 31 May 2026 | 46.8 | 80.1 | 40.4 | 5.3 | 172.6 |
| Accumulated depreciation and impairment | |||||
At 1 June 2024 | 25.4 | 67.8 | 43.5 | — | 136.7 |
Depreciation charge | 0.7 | 3.2 | 1.2 | — | 5.1 |
Disposals | — | (1.6) | (7.8) | — | (9.4) |
Exchange differences | (0.2) | (2.3) | (0.5) | — | (3.0) |
At 31 May 2025 | 25.9 | 67.1 | 36.4 | — | 129.4 |
Depreciation charge | 1.4 | 3.0 | 1.2 | — | 5.6 |
Disposals | (3.9) | (1.5) | (0.8) | — | (6.2) |
Exchange differences | 0.3 | (0.6) | 0.1 | — | (0.2) |
At 31 May 2026 | 23.7 | 68.0 | 36.9 | — | 128.6 |
| Net book value | |||||
At 31 May 2026 | 23.1 | 12.1 | 3.5 | 5.3 | 44.0 |
At 31 May 2025 | 24.0 | 11.4 | 3.2 | 4.8 | 43.4 |
2026 | 2025 | |
£m | £m | |
| Cost | ||
At 1 June | 10.6 | 7.2 |
Additions | — | 0.2 |
Disposals | (8.0) | — |
Hyperinflation impact 1 | — | 2.7 |
Exchange differences | (0.9) | 0.5 |
At 31 May | 1.7 | 10.6 |
| Accumulated depreciation and impairment | ||
At 1 June | 0.6 | 0.6 |
Depreciation charge | — | 0.1 |
Disposals | (0.1) | — |
Exchange differences | — | (0.1) |
At 31 May | 0.5 | 0.6 |
| Net book value | ||
At 31 May | 1.2 | 10.0 |
| Land and | Motor | Other | ||
| buildings | vehicles | equipment | Total | |
£m | £m | £m | £m | |
Additions | — | 0.5 | 0.3 | 0.8 |
Depreciation charge in the year | (2.3) | (0.2) | (0.3) | (2.8) |
Net book value at 31 May 2026 | 10.3 | 0.4 | 0.8 | 11.5 |
| £m | |
| At 1 June 2024 | — |
| Share of results of joint venture | 5.6 |
Exchange differences | (1.0) |
Reclassification to assets held for sale | (4.6) |
At 31 May 2025 and 31 May 2026 | — |
| 2025 | |
| £m | |
| Assets | |
Non-current assets | 25.7 |
| Current assets | |
Cash and cash equivalents | 4.5 |
Other current assets | 51.2 |
| 55.7 | |
Total assets | 81.4 |
| Liabilities | |
Non-current liabilities | (47.7) |
Current liabilities | (24.4) |
Total liabilities | (72.1) |
Net assets | 9.3 |
| 2025 | |
| £m | |
Revenue | 189.6 |
Profit before taxation | 15.8 |
Profit after taxation | 11.1 |
Proportion of Group's ownership interest in the joint venture | 50% |
Share of results of joint venture | 5.6 |
2026 | 2025 | |
£m | £m | |
Raw materials and consumables | 14.1 | 11.9 |
Work in progress | 8.8 | 4.7 |
Finished goods and goods for resale | 55.9 | 53.4 |
78.8 | 70.0 |
2026 | 2025 | |
£m | £m | |
Trade receivables | 84.9 | 76.7 |
Less: loss allowance | (2.0) | (1.9) |
Net trade receivables | 82.9 | 74.8 |
Lease receivables | 1.9 | 1.2 |
Amounts owed by joint venture | — | 27.1 |
Other receivables | 11.7 | 12.6 |
Prepayments | 4.6 | 5.6 |
101.1 | 121.3 | |
| Classified within: | ||
Current assets | 99.2 | 119.2 |
Non-current assets | 1.9 | 2.1 |
101.1 | 121.3 |
2026 | 2025 | |
£m | £m | |
At 1 June | (1.9) | (2.6) |
Increase in loss allowance | (1.7) | (0.8) |
Allowance used during the year | — | 0.1 |
Allowance released during the year | 1.6 | 1.4 |
At 31 May | (2.0) | (1.9) |
2026 | 2025 | |
£m | £m | |
Pound Sterling | 30.1 | 29.0 |
US Dollar | 9.7 | 11.7 |
Nigerian Naira | 7.3 | 3.5 |
Australian Dollar | 17.8 | 12.5 |
Indonesian Rupiah | 12.7 | 12.8 |
Other currencies | 5.3 | 5.3 |
82.9 | 74.8 |
| Foreign | |||||
| exchange | |||||
1 June 2025 | Net cash flow | movements | Other 1 | 31 May 2026 | |
£m | £m | £m | £m | £m | |
Cash at bank and in hand | 38.1 | 4.6 | 2.7 | — | 45.4 |
Short-term deposits | 7.0 | (0.5) | — | — | 6.5 |
Cash and cash equivalents 2 | 45.1 | 4.1 | 2.7 | — | 51.9 |
Current borrowings | (54.7) | 55.0 | — | (70.2) | (69.9) |
Non-current borrowings | (102.4) | 25.5 | — | 69.9 | (7.0) |
Net debt | (112.0) | 84.6 | 2.7 | (0.3) | (25.0) |
Lease liabilities | (14.9) | 3.0 | — | (1.0) | (12.9) |
Net debt including lease liabilities | (126.9) | 87.6 | 2.7 | (1.3) | (37.9) |
| Foreign | |||||
| exchange | |||||
1 June 2024 | Net cash flow | movements | Other 1 | 31 May 2025 | |
£m | £m | £m | £m | £m | |
Cash at bank and in hand | 49.4 | (9.7) | (1.6) | — | 38.1 |
Short-term deposits | 1.9 | 5.2 | (0.1) | — | 7.0 |
Cash and cash equivalents 2 | 51.3 | (4.5) | (1.7) | — | 45.1 |
Current borrowings | (6.3) | 6.2 | 0.1 | (54.7) | (54.7) |
Non-current borrowings | (160.3) | 3.5 | — | 54.4 | (102.4) |
Net debt | (115.3) | 5.2 | (1.6) | (0.3) | (112.0) |
Lease liabilities | (12.1) | 3.3 | 0.2 | (6.3) | (14.9) |
Net debt including lease liabilities | (127.4) | 8.5 | (1.4) | (6.6) | (126.9) |
2026 | 2025 | |
£m | £m | |
| Derivatives designated as hedging instruments at FVTOCI | ||
Forward foreign exchange contracts | — | 0.3 |
| Derivatives not designated as hedging instruments at FVTPL | ||
Forward foreign exchange contracts | 0.1 | 0.1 |
| Financial assets at amortised cost | ||
Cash and cash equivalents | 51.9 | 45.1 |
Net trade and other receivables | 94.6 | 87.4 |
Lease receivables | 1.9 | 1.2 |
Trade receivables owed by joint venture | — | 0.7 |
Loan receivables owed by joint venture | — | 26.4 |
148.5 | 161.2 | |
| Classified within: | ||
Current assets | 146.6 | 159.1 |
Non-current assets | 1.9 | 2.1 |
148.5 | 161.2 |
2026 | 2025 | |
£m | £m | |
| Current interest-bearing borrowings at amortised cost | ||
Borrowings | 69.9 | 54.7 |
| Non-current interest-bearing borrowings at amortised cost | ||
Borrowings | 7.0 | 102.4 |
| Derivatives designated as hedging instruments at FVTOCI | ||
Forward foreign exchange contracts | 0.8 | 0.2 |
| Derivatives not designated as hedging instruments at FVTPL | ||
Forward foreign exchange contracts | 1.3 | 0.2 |
| Other financial liabilities at amortised cost | ||
Trade and other payables 1 | 160.1 | 149.3 |
Lease liabilities | 12.9 | 14.9 |
252.0 | 321.7 | |
| Classified within: | ||
Current liabilities | 233.4 | 206.1 |
Non-current liabilities | 18.6 | 115.6 |
252.0 | 321.7 |
| Foreign | |||||
| exchange | |||||
1 June 2025 | Net cash flow | movements | Other | 31 May 2026 | |
£m | £m | £m | £m | £m | |
Non-current borrowings | (102.4) | 25.5 | — | 69.9 | (7.0) |
Current borrowings | (54.7) | 55.0 | — | (70.2) | (69.9) |
Non-current lease liabilities | (12.6) | 0.7 | — | 1.4 | (10.5) |
Current lease liabilities | (2.3) | 2.3 | — | (2.4) | (2.4) |
Notional | Fair value | ||||||
| Local | Weighted | GBP | |||||
| currency | average | equivalent | Average spot | Asset | Liability | ||
| 2026 | million | Currency pair | hedge rate | £m | rate | £m | £m |
Buy USD | 11.6 | GBP:USD | 1.34 | (8.7) | 1.34 | 0.1 | (0.2) |
Buy EUR | 4.6 | GBP:EUR | 1.14 | (4.0) | 1.15 | — | — |
Buy AUD | 7.1 | GBP:AUD | 1.85 | (3.8) | 2.00 | — | (0.2) |
Buy USD | 27.9 | AUD:USD | 0.68 | (21.8) | 0.67 | — | (1.1) |
Buy IDR | 261,777.8 | GBP:IDR | 22,819 | (11.5) | 22,433 | — | (0.6) |
0.1 | (2.1) |
Notional | Fair value | ||||||
| Weighted | GBP | ||||||
| Currency | average | equivalent | Average spot | Asset | Liability | ||
| 2025 | million | Currency pair | hedge rate | £m | rate | £m | £m |
Sell USD | (13.8) | GBP:USD | 1.35 | 10.2 | 1.29 | — | — |
Buy EUR | 6.4 | GBP:EUR | 1.18 | (5.4) | 1.19 | 0.1 | (0.1) |
Sell AUD | (8.7) | GBP:AUD | 2.05 | 4.2 | 1.99 | 0.1 | — |
Buy USD | 24.1 | AUD:USD | 0.64 | (17.8) | 0.65 | 0.2 | (0.2) |
Buy IDR | 207,317.0 | GBP:IDR | 21,647 | (9.6) | 20,742 | — | (0.1) |
0.4 | (0.4) |
2026 | 2025 | |
£m | £m | |
At 1 June | (0.2) | (0.4) |
Fair value (losses)/gains, net of taxation | (0.6) | 0.2 |
At 31 May | (0.8) | (0.2) |
2026 | 2025 | |||
| Impact | Impact on | Impact on | Impact | |
| on profit | pre-tax | loss before | on pre-tax | |
| £m | before tax | equity | tax | equity |
US Dollar | (0.6) | 0.1 | (1.4) | 1.5 |
Nigerian Naira | 2.3 | — | 3.8 | — |
2026 | 2025 | |||||
Impact on | Impact on | Impact on | Impact on | Impact on | Impact on | |
adjusted | operating | total | adjusted | operating | total | |
£m | operating profit | loss | equity | operating profit | loss | equity |
Nigerian Naira | (1.6) | (1.5) | (7.4) | (1.7) | (1.4) | (5.6) |
Indonesian Rupiah | (1.2) | (1.6) | (0.1) | (1.0) | (1.0) | (0.5) |
Australian Dollar | (1.0) | (1.0) | (0.7) | (1.3) | (1.2) | (0.8) |
Other | (0.6) | (1.1) | (2.6) | (0.6) | (0.6) | (2.2) |
| Effect on profit/(loss) before tax | |||
Increase/decrease | 2026 | 2025 | |
in basis points | £m | £m | |
Nigerian Naira rates | +50.0 | — | 0.1 |
-50.0 | — | (0.1) |
| Effect on profit/(loss) before tax | |||
Increase/decrease | 2026 | 2025 | |
in basis points | £m | £m | |
| GBP rates | +50.0 | (0.4) | (0.8) |
| -50.0 | 0.4 | 0.8 |
2026 | 2025 | |||
| Cash and cash | Financial | Cash and cash | Financial | |
| equivalents | derivatives | equivalents | derivatives | |
£m | £m | £m | £m | |
AA- | 22.8 | — | 4.1 | 0.2 |
A+ to A- | 2.8 | 0.1 | 19.6 | 0.2 |
BBB+ to BBB- | 0.1 | — | 0.4 | — |
BB+ to BB- | 0.6 | — | — | — |
B+ to B- | 25.6 | — | 20.8 | — |
not rated | — | — | 0.2 | — |
51.9 | 0.1 | 45.1 | 0.4 |
Expected credit | Gross trade | Lifetime expected | Net trade | |
loss rate | receivables | credit loss | receivables | |
At 31 May 2026 | % | £m | £m | £m |
Not past due | 0.0% | 63.1 | — | 63.1 |
Past due 0-30 days | 0.6% | 16.4 | (0.1) | 16.3 |
Past due 31-60 days | 5.0% | 2.0 | (0.1) | 1.9 |
Past due 61-90 days | 20.0% | 0.5 | (0.1) | 0.4 |
Past due 91-180 days | 41.7% | 1.2 | (0.5) | 0.7 |
Past due >180 days | 70.6% | 1.7 | (1.2) | 0.5 |
Total | 84.9 | (2.0) | 82.9 |
Expected credit | Gross trade | Lifetime expected | Net trade | |
loss rate | receivables | credit loss | receivables | |
At 31 May 2025 | % | £m | £m | £m |
Not past due | 0.0% | 65.2 | — | 65.2 |
Past due 0-30 days | 1.4% | 7.0 | (0.1) | 6.9 |
Past due 31-60 days | 12.5% | 0.8 | (0.1) | 0.7 |
Past due 61-90 days | 9.1% | 1.1 | (0.1) | 1.0 |
Past due 91-180 days | 11.1% | 0.9 | (0.1) | 0.8 |
Past due >180 days | 88.2% | 1.7 | (1.5) | 0.2 |
Total | 76.7 | (1.9) | 74.8 |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2026 | £m | £m | £m | £m | £m | £m |
Trade and other payables | (150.5) | (15.3) | (1.1) | — | — | (166.9) |
Forward foreign exchange contracts | (42.3) | (29.2) | — | — | — | (71.5) |
Borrowings | — | (71.5) | (7.0) | — | — | (78.5) |
Lease liabilities | (0.7) | (2.2) | (2.9) | (5.6) | (3.0) | (14.4) |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2025 | £m | £m | £m | £m | £m | £m |
Trade and other payables | (143.3) | (11.8) | (0.6) | — | — | (155.7) |
Forward foreign exchange contracts | (33.2) | (23.6) | — | — | — | (56.8) |
Borrowings (restated) 1 | (0.1) | (56.2) | (76.1) | (32.5) | — | (164.9) |
Lease liabilities | (0.7) | (2.1) | (2.7) | (6.9) | (4.0) | (16.4) |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2026 | £m | £m | £m | £m | £m | £m |
Inflows | 41.1 | 28.5 | — | — | — | 69.6 |
Outflows | (42.4) | (29.2) | — | — | — | (71.6) |
Net | (1.3) | (0.7) | — | — | — | (2.0) |
| Carrying amounts: | ||||||
Asset | 0.1 | — | — | — | — | 0.1 |
Liability | (1.4) | (0.7) | — | — | — | (2.1) |
(1.3) | (0.7) | — | — | — | (2.0) |
<3 months | 3-12 months | 1-2 years | 2-5 years | >5 years | Total | |
At 31 May 2025 | £m | £m | £m | £m | £m | £m |
Inflows | 33.4 | 23.4 | — | — | — | 56.8 |
Outflows | (33.2) | (23.6) | — | — | — | (56.8) |
Net | 0.2 | (0.2) | — | — | — | — |
| Carrying amounts: | ||||||
Asset | 0.3 | 0.1 | — | — | — | 0.4 |
Liability | (0.1) | (0.3) | — | — | — | (0.4) |
0.2 | (0.2) | — | — | — | — |
Level 1 | Level 2 | Level 3 | Total | |
At 31 May 2026 | £m | £m | £m | £m |
| Assets held at fair value | ||||
Derivative financial assets | — | 0.1 | — | 0.1 |
| Liabilities held at fair value | ||||
Derivative financial liabilities | — | 2.1 | — | 2.1 |
Level 1 | Level 2 | Level 3 | Total | |
At 31 May 2025 | £m | £m | £m | £m |
| Assets held at fair value | ||||
Derivative financial assets | — | 0.4 | — | 0.4 |
| Liabilities held at fair value | ||||
Derivative financial liabilities | — | 0.4 | — | 0.4 |
2026 | 2025 | |
£m | £m | |
| Current | ||
Trade payables | 75.1 | 72.5 |
Other taxation and social security | 6.8 | 6.4 |
Other payables | 3.4 | 4.9 |
Accruals | 80.5 | 71.3 |
165.8 | 155.1 | |
| Non-current | ||
Other payables | 1.1 | 0.6 |
| Property, | Retirement | ||||||
| plant and | benefit | Business | Accruals and | Tax losses/ | Other timing | ||
| equipment | obligations | combinations | provisions | (gains) | differences | Total | |
£m | £m | £m | £m | £m | £m | £m | |
At 1 June 2024 | (7.2) | (5.1) | (39.2) | 1.5 | 36.8 | (4.4) | (17.6) |
Credit/(charge) to income statement | 0.8 | — | (4.1) | (0.6) | (8.0) | 12.9 | 1.0 |
Credit/(charge) to other comprehensive income | — | 1.2 | 0.9 | — | — | (1.6) | 0.5 |
Exchange differences | 0.1 | (0.1) | — | (0.2) | (2.0) | — | (2.2) |
At 31 May 2025 | (6.3) | (4.0) | (42.4) | 0.7 | 26.8 | 6.9 | (18.3) |
Credit/(charge) to income statement | 0.4 | — | (4.8) | (0.1) | (6.9) | (5.8) | (17.2) |
Credit/(charge) to other comprehensive income | — | 0.8 | (1.1) | — | — | 2.4 | 2.1 |
Exchange differences | (0.2) | (0.3) | — | 0.1 | 1.6 | (0.1) | 1.1 |
At 31 May 2026 | (6.1) | (3.5) | (48.3) | 0.7 | 21.5 | 3.4 | (32.3) |
2026 | 2025 | |
£m | £m | |
Deferred tax assets | 13.0 | 15.8 |
Deferred tax liabilities | (45.3) | (34.1) |
(32.3) | (18.3) |
| Warranty | |
| provisions | |
| £m | |
At 1 June 2024 | 0.2 |
Additions | 0.1 |
At 31 May 2025 | 0.3 |
Additions | 0.2 |
Utilisation | (0.1) |
At 31 May 2026 | 0.4 |
Risk | Description | Mitigation |
Investment risk | The present value of the defined benefit pension schemes’ | As part of the financing of the funded schemes, they invest in |
| liabilities is calculated using a discount rate (investment | assets with higher return expectations than lower risk bonds | |
| return) determined by direct reference to high-quality | that are the best match for the schemes’ liabilities. To control | |
| corporate bond yields (for IAS 19 Employee Benefits purposes) | the resulting investment risk, the funded schemes invest | |
| and gilt yields (for statutory funding and long-term funding | in diversified portfolios of growth assets with the balances | |
| purposes). If the return on scheme assets is less than these | invested in liability-matching bond assets designed to control | |
| discount rates, the funding position of the schemes will fall. | interest rate risk (see below). The split between growth assets | |
| and liability-matching bond assets for each funded scheme is | ||
| regularly monitored to ensure investment risk is not excessive | ||
| given the statutory funding assumptions and the schemes’ | ||
| long-term funding objectives. | ||
Interest risk | A decrease in the corporate bond yield and/or gilt yield will | The funded schemes make use of liability-driven investment |
| increase the present value of the schemes’ liabilities under | techniques to protect them against the majority of the interest | |
| IAS 19 Employee Benefits and statutory/long-term funding | rate risk inherent in their liabilities. This is achieved by investing | |
| bases respectively. | in gilts and investment grade corporate bonds such that | |
| changes in the schemes’ liabilities due to falling gilt and/or | ||
| corporate bond yields are offset by similar movements in the | ||
| value of the schemes’ overall assets. | ||
| Reflecting the funded schemes’ focus on controlling interest | ||
| risk relative to their statutory and long-term funding bases, the | ||
| schemes’ liability matching bond portfolios are predominantly | ||
| invested in gilts, with the balance invested in investment grade | ||
| corporate bonds to increase the expected return on the plans’ | ||
| assets in a risk-controlled way. In doing so, the exposures | ||
| to investment grade corporate bonds also help mitigate the | ||
| interest rate risk inherent in the schemes’ IAS 19 Employee | ||
| Benefits liabilities. | ||
Inflation risk | Benefits in payment and deferred benefits attract increases | The schemes’ liability-matching bond assets are also designed |
| which are linked to inflation, therefore an increase in the | to hedge the majority of the inflation rate risk inherent in the | |
| assumed future rate of inflation will increase the present value | schemes’ liabilities. This is achieved by investing in index- | |
| of the schemes’ liabilities under IAS 19 Employee Benefits and | linked gilts. | |
| statutory/long-term funding bases. | ||
Longevity risk | The value of the schemes’ liabilities is calculated by reference | To help control longevity risk all the schemes are closed to |
| to the best estimate of the life expectancy of each schemes’ | future benefit accrual. | |
| participants. An increase in life expectancy of the schemes’ | The schemes consider additional approaches to mitigating | |
| participants will increase the schemes’ liabilities. | ||
| longevity risk, for example by buying annuities with an | ||
| insurance company to cover the schemes’ liabilities. |
2026 | 2025 | |||||
Assets | Obligations | Total | Assets | Obligations | Total | |
£m | £m | £m | £m | £m | £m | |
Main plan | 131.5 | (118.9) | 12.6 | 135.4 | (120.2) | 15.2 |
Directors' plan | 26.9 | (14.9) | 12.0 | 27.4 | (15.2) | 12.2 |
Expatriate plan | 78.8 | (39.0) | 39.8 | 78.4 | (39.5) | 38.9 |
Unfunded plan | — | (2.8) | (2.8) | — | (2.8) | (2.8) |
237.2 | (175.6) | 61.6 | 241.2 | (17 7.7 ) | 63.5 | |
Restrictions due to asset ceiling | (39.8) | (38.9) | ||||
Net asset | 21.8 | 24.6 | ||||
| Classified as/within: | ||||||
Retirement benefit surplus | 24.6 | 27.4 | ||||
| Retirement benefit and other long-term employee | (2.8) | (2.8) | ||||
| obligations | 21.8 | 24.6 |
2026 | 2025 | |
£m | £m | |
At 1 June | 241.2 | 266.2 |
| Recognised in Consolidated Income Statement: | ||
– administrative expense | (1.4) | (1.0) |
– finance income | 11.3 | 11.3 |
| Recognised in Consolidated Statement of Other Comprehensive Income: | ||
– return on plan assets (excluding finance income) | (0.6) | (18.4) |
| Not recognised within comprehensive income due to asset ceiling: | ||
– finance income | 2.3 | 2.2 |
– return on plan assets (excluding finance income) | (1.3) | (5.6) |
Employer contributions to the Unfunded plan | 0.1 | 0.2 |
Benefits paid | (14.4) | (13.7) |
At 31 May | 237.2 | 241.2 |
2026 | 2025 | |
£m | £m | |
Equities | — | 2.5 |
Bonds | 226.9 | 226.2 |
Insured annuities | 0.4 | 0.4 |
Cash and cash equivalents | 9.9 | 12.1 |
237.2 | 241.2 |
2026 | 2025 | |
£m | £m | |
At 1 June | (177.7) | (19 5.1) |
| Recognised in Consolidated Income Statement: | ||
– finance expense | (9.9) | (9.8) |
| Recognised in Consolidated Statement of Comprehensive Income: | ||
– re-measurement (loss)/gain due to changes in demographic assumptions | (0.3) | 3.3 |
– re-measurement (loss)/gain due to changes in financial assumptions | (1.7) | 18.6 |
– re-measurement loss due to experience adjustments | (0.4) | (8.4) |
Benefits paid | 14.4 | 13.7 |
At 31 May | (175.6) | (17 7.7 ) |
2026 | 2025 | |
£m | £m | |
Administrative expense | (1.4) | (1.0) |
Finance income | 1.4 | 1.5 |
— | 0.5 |
2026 | 2025 | |
£m | £m | |
| Relating to plan assets: | ||
– return on plan assets (excluding finance income) | (0.6) | (18.4) |
| Relating to plan defined benefit obligations: | ||
– re-measurement (loss)/gain due to changes in demographic assumptions | (0.3) | 3.3 |
– re-measurement (loss)/gain due to changes in financial assumptions | (1.7) | 18.6 |
– re-measurement loss due to experience adjustments | (0.4) | (8.4) |
(3.0) | (4.9) |
2026 | 2025 | |
| Rate of increase in retirement benefits in payment | ||
– pensions in payment | 2.9% | 2.7% |
– deferred pensions | 2.7% | 2.4% |
Discount rate | 5.9% | 5.8% |
Inflation (RPI) | 3.1% | 2.9% |
2026 | 2025 | |
years | years | |
| Weighted average life expectancy on post-retirement mortality table used to determine benefit obligations | ||
– Member age 65 (current life expectancy) | 22.2 | 21.9 |
– Member age 45 (life expectancy at age 65) | 23.3 | 23.0 |
Change in assumption | Change in obligation | |
Discount rate | Decrease of 0.25% | Increase of 2.5% |
Inflation (RPI) | Increase of 0.25% | Increase of 2.3% |
Mortality | Increase in life expectancy of 1 year | Increase of 3.3% |
2026 | 2025 | |||||
Assets | Obligations | Total | Assets | Obligations | Total | |
£m | £m | £m | £m | £m | £m | |
Net liability | 0.4 | (8.7) | (8.3) | — | (8.9) | (8.9) |
2026 | 2025 | |
£m | £m | |
At 1 June | — | — |
Employer contributions to the Unfunded plan | 0.6 | — |
Benefits paid | (0.2) | — |
At 31 May | 0.4 | — |
2026 | 2025 | |
£m | £m | |
At 1 June | (8.9) | (9.0) |
| Recognised in Consolidated Income Statement: | ||
– administrative expenses | (1.1) | (1.2) |
– finance expenses | (0.6) | (0.6) |
| Recognised in Consolidated Statement of Comprehensive Income: | ||
– re-measurement (loss)/gain | (0.1) | 0.3 |
Benefits paid | 1.1 | 0.9 |
Exchange differences | 0.9 | 0.7 |
At 31 May | (8.7) | (8.9) |
Change in assumption | Change in obligation | |
Discount rate | Decrease of 1.0% | Increase of 7.6% |
Salary rate | Increase of 1.0% | Increase of 7.7% |
2026 | 2025 | |||
Number | Number | |||
000 | £m | 000 | £m | |
| Authorised, allotted, issued and fully paid: | ||||
Ordinary shares of 1p each | 428,725 | 4.3 | 428,725 | 4.3 |
Total called up share capital | 428,725 | 4.3 | 428,725 | 4.3 |
| SIP trust | ||
| ESOT number | number | |
At 1 June 2024 | 9,233,743 | 202,443 |
Issued to satisfy options | (688,843) | — |
Transfers | (173,509) | 173,509 |
At 31 May 2025 | 8,371,391 | 375,952 |
Issued to satisfy options | (793,146) | — |
Transfers | (18 3,14 4) | 183,144 |
At 31 May 2026 | 7,395,101 | 559,096 |
Performance | Restricted | Deferred | |||
shares | shares | bonus shares | SIP | Total | |
number | number | number | number | number | |
Options/awards outstanding as at 1 June 2024 | 2,367,165 | 3,224,971 | 379,788 | 199,165 | 6,171,089 |
Options/awards issued | 5,985 | 4,033,454 | 441,587 | 198,097 | 4,679,123 |
Options/awards exercised 1 | (91,733) | (466,782) | (129,173) | (519) | (688,207) |
Options/awards lapsed/forfeited 2 | (1,056,785) | (887,873) | — | (25,313) | (1,969,971) |
Options/awards outstanding as at 31 May 2025 | 1,224,632 | 5,903,770 | 692,202 | 371,430 | 8,192,034 |
Options/awards issued | 22,171 | 4,357,577 | 641,195 | 227,068 | 5,248,011 |
Options/awards exercised 1 | (2 07,171) | (485,699) | (100,076) | (28,337) | (821,283) |
Options/awards lapsed/forfeited 2 | (1,039,632) | (743,657) | (421,014) | (43,997) | (2,248,300) |
Options/awards outstanding as at 31 May 2026 | — | 9,031,991 | 812,307 | 526,164 | 10,370,462 |
Restricted | Deferred | |||
shares | bonus shares | SIP | Total | |
number | number | number | number | |
31 May 2026 and earlier 1 | — | — | 70,972 | 70,972 |
31 May 2027 | 1,667,029 | 397,836 | 89,607 | 2,154,472 |
31 May 2028 | 3,104,763 | 414,471 | 155,576 | 3,674,810 |
31 May 2029 | 4,260,199 | — | 210,009 | 4,470,208 |
Total | 9,031,991 | 812,307 | 526,164 | 10,370,462 |
Note | 2026 | 2025 | |
£m | £m | ||
Profit before taxation 1 | 77.4 | 6.5 | |
Net finance expense | 9.4 | 14.1 | |
Operating profit | 86.8 | 20.6 | |
Depreciation | 11,12,13 | 8.4 | 8.0 |
Amortisation | 10 | 4.1 | 4.1 |
Impairment of intangible assets | 10 | 13.0 | 35.3 |
Impairment reversal of intangible assets | 10 | (24.4) | (16.5) |
Impairment reversal of current asset investment | — | (0.5) | |
Profit on disposal of joint venture undertakings | 29 | (4.5) | — |
Add back transaction costs on disposal of joint venture undertakings | 29 | (1.9) | — |
Profit on disposal of investment properties | 4 | (12.6) | (0.8) |
Add back transaction costs on disposal of investment properties | (1.7) | — | |
Profit on disposal of other assets | 4 | — | (0.3) |
Difference between pension charge and cash contributions | 1.2 | 1.1 | |
Share-based payments | 3.3 | 2.6 | |
Rental income classified as investing cash flows | (1.2) | (1.1) | |
Share of results of joint venture | — | (5.6) | |
Operating cash flows before movements in working capital | 70.5 | 46.9 | |
| Movements in working capital: | |||
Inventories | (4.2) | (5.6) | |
Trade and other receivables | (5.8) | 1.6 | |
Trade and other payables | 0.2 | 5.6 | |
Provisions | 0.1 | 0.7 | |
Cash generated from operations | 60.8 | 49.2 |
2026 | 2025 | |
£m | £m | |
Short-term employee benefits | 2.2 | 2.4 |
Post-employment benefits | 0.1 | 0.1 |
Share-based payments | 1.2 | 1.2 |
3.5 | 3.7 |
| Parent | Proportion | |||||
| Country of | Company’s | of voting | ||||
Company | Operation | incorporation | interest | interest | Registered office address | |
PZ Cussons (Holdings) Pty Limited | Holding company | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 |
PZ Cussons Australia Pty Limited | Manufacturing | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 |
| PZ Cussons Beauty Australia | Holding company | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 |
| (Holdings) Pty Limited | ||||||
Rafferty’s Garden Pty Limited | Dormant | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 |
United Laboratories Limited | Dormant | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 |
| PZ Cussons (New Zealand) Pty | Distribution | Australia | 100% | 100% | Level 3, 510 | Church Street Cremorne Victoria 3121 |
| Limited | ||||||
| Paterson Services (Shanghai) | Provision of services | China | 100% | 100% | Suite 635, 6th Floor, No.2000 Pudong Ave. China | |
| Limited | to Group companies | (Shanghai) Pilot Free Trade Zone | ||||
Bronson Holdings Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
Milk Ventures (UK) Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
| PZ Cussons (Africa Holdings) | Dormant | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Limited | Manchester, M22 5TG | |||||
PZ Cussons (Holdings) Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
| PZ Cussons (International Finance) | Provision of services | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Limited | to Group companies | Manchester, M22 5TG | ||||
| PZ Cussons (International) Limited | Provision of services | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| to Group companies | Manchester, M22 5TG | |||||
PZ Cussons (UK) Limited | Manufacturing | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
PZ Cussons Beauty LLP 1 | Distribution & | England | 100% | — | Manchester Business Park, 3500 Aviator Way, | |
| holding partnership | Manchester, M22 5TG | |||||
Seven Scent Limited | Manufacturing | England | 100% | 100% | Agecroft Commerce Park, Lamplight Way, Swinton, | |
| Manchester, M27 8UJ | ||||||
St. Tropez Acquisition Co. Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
St. Tropez Holdings Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
St. Tropez Operations Limited | Dormant | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
| Parent | Proportion | |||||
| Country of | Company’s | of voting | ||||
Company | Operation | incorporation | interest | interest | Registered office address | |
| Thermocool Engineering Company | Dormant | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Limited | Manchester, M22 5TG | |||||
PZ Cussons Acquisition Co Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
Tadley Holdings Limited | Holding company | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
Childs Farm Ltd | Distribution | England | 100% | 100% | Manchester Business Park, 3500 Aviator Way, | |
| Manchester, M22 5TG | ||||||
PZ Cussons Ghana PLC | Distribution | Ghana | 100% | 100% | Plot 27/3-27/7, Sanyo Road, Tema, P. O. Box 628 | |
| Community 1, Tema | ||||||
PZ Cussons (Hong Kong) Limited | Dormant | Hong Kong | 100% | 100% | Level 54, Hopewell Centre, 183 Queen’s Road East | |
| Provision of services | 604, 'C' Wing Raylon Arcade Ram Mandir Road – | |||||
| PZ Cussons India PVT Limited | to Group companies | India | 100% | 100% | Kondvita Road, Bhim Nagar, Andheri East, Mumbai | |
| 400093 | ||||||
PT PZ Cussons Indonesia | Manufacturing | Indonesia | 100% | 100% | Jalan Halim Perdana Kusuma No. 144, Kebon Besar, | |
| Batuceper, Tangerang, Banten, Indonesia | ||||||
PZ Cussons (Europe) Limited | Dormant | Ireland | 100% | 100% | The Greenway Ardilaun Court, 112-114 St Stephen’s | |
| Green, Dublin, DO2 TD28, Ireland | ||||||
Childs Farm Europe Ltd | Dormant | Ireland | 100% | 100% | 4th Floor, 103/104 O’Connell Street, Limerick V94 | |
| AT85, Co. Limerick, Ireland | ||||||
PZ Cussons East Africa Limited | Manufacturing | Kenya | 99.99% | 99.99% | Baba Dogo Road, Ruaraka, Nairobi, Kenya | |
Food For Life International Limited | Dormant | Nigeria | 99.99% | 99.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
Harefield Industrial Nigeria Limited | Distribution | Nigeria | 99.99% | 99.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
HPZ Limited 2 | Manufacturing | Nigeria | 74.99% | 74.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
Nutricima Limited | Dormant | Nigeria | 99.99% | 99.99% | 45/47 Town Planning Way, Ilupeju, Lagos | |
PZ Cussons Nigeria PLC | Manufacturing | Nigeria | 73.27% | 73.27% | 45/47 Town Planning Way, Ilupeju, Lagos | |
Roberts Pharmaceuticals Limited | Dormant | Nigeria | 100% | 100% | 45/47 Town Planning Way, Ilupeju, Lagos | |
PZ Cussons Polska S.A. | Distribution | Poland | 100% | 100% | Ul. Chocimska 17, 00-791 Warszawa | |
| PZ Cussons Singapore Private | Provision of services | Singapore | 100% | 100% | 5 Shenton Way, UIC Building #10-01, Singapore | |
| Limited | to Group companies | 068808 | ||||
| Guardian Holdings Company | Provision of services | 35 Moo 4, Tessamphan Road, Ban Chang Sub- | ||||
| Limited | to Group companies | Thailand | 49.00% | 49.00% | District, Mueang Pathum Thani District, Pathum | |
| Thani Province | ||||||
| 35 Moo 4, Tessamphan Road, Ban Chang Sub- | ||||||
PZ Cussons (Thailand) Limited | Manufacturing | Thailand | 99.99% | 99.99% | District, Mueang Pathum Thani District, Pathum | |
| Thani Province | ||||||
| PZ Cussons Middle East and South | Dormant | UAE | 100% | 100% | PO Box 17233, | Jebel Ali, Dubai |
| Asia FZE | ||||||
St. Tropez Inc. | Distribution | USA | 100% | 100% | 413 | East Lancaster Avenue, Wayne, PA 19087 |
Childs Farm, Inc. | Distribution | USA | 100% | 100% | 413 | East Lancaster Avenue, Wayne, PA 19087 |
| £m | |
Total proceeds | 24.6 |
| Net assets disposed: | |
Investment in joint venture undertaking | (4.6) |
Cumulative currency translation adjustment | (13.6) |
Transaction costs incurred in the year ended 31 May 2026 | (1.9) |
Gain on disposal – recognised within adjusting items | 4.5 |
Transaction costs incurred within the year ended 31 May 2025 | (1.4) |
Overall gain on disposal | 3.1 |